Navigation Links
Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
Date:10/5/2007

BOSTON, Oct. 5 /PRNewswire/ -- Surface Logix, Inc. today announced the presentation of positive safety and efficacy data from its innovative Phase 1 repeat-dose clinical trial of its investigational drug candidate SLx-4090, a first-in-class enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor being developed for the treatment of dyslipidemia (abnormal levels of lipids in the bloodstream). The data indicated not only that repeat- dosing at all dose levels of SLx-4090 was well tolerated, with no serious adverse events reported, but also that SLx-4090 significantly decreased plasma levels of both triglyceride and LDL-cholesterol compared to placebo. These data extend earlier findings previously reported from a single-dose study relating to the safety, tolerability and pharmacokinetic and pharmacodynamic profiles of SLx-4090. Results were presented at the 16th International Symposium on Drugs Affecting Lipid Metabolism being held October 4-7 in New York, NY.

"It is exciting that this novel compound continued to perform so well in this first repeat-dose study," said Dr. William Prince, Chief Development Officer of Surface Logix. "Consistent with our preclinical and Phase 1 single-dose results, no drug was detected in the plasma at doses up to 200 mg given three times daily for two weeks. This is particularly notable, as all other known MTP inhibitors have been shown to enter the systemic circulation and negatively impact standard measures of liver function. SLx-4090 was extremely well tolerated and adverse events were similar to those seen with placebo."

"Based on the results of this study, we have advanced SLx-4090 into a Phase 2a study, which will be completed shortly, and initial results are confirming the profile seen in both Phase 1 studies," said Jim Mahoney, President and Chief Executive Officer of Surface Logix. "We are also planning to start a Phase 2b study in patients with dyslipidemia in the middle of 2008. Based on
'/>"/>

SOURCE Surface Logix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
2. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 Townsend Design announced the ... Reliever, a soft shell single-upright osteoarthritis (OA) knee brace. ... relieve pain by reducing load on the side of ... Sales of the product in other countries will begin ... sewn-in integrated semi rigid frame and quick release buckles ...
(Date:5/21/2015)... Md. , May 21, 2015 ... open innovation competition designed to bring promising medical ... Heritage Provider Network (HPN) in collaboration with the ... for Advancing Innovation (CAI).  The winning teams were ... and live pitches and will move forward to ...
(Date:5/21/2015)... BOSTON , May 21, 2015  Juniper ... specialty pharmaceutical company focused on developing therapeutics that ... announced that CEO Frank Condella will ... as follows:Date: , Thursday, June 4, 2015Time: , ... & archive): , www.juniperpharma.com, under  ,Investor, ...
Breaking Medicine Technology:Townsend Announces Launch Of New Osteoarthritis Knee Brace 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 3Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 4Juniper Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference on June 4, 2015 2
... ULURU Inc. (NYSE AMEX: ... development of a portfolio of wound management and oral ... for investment commitments with Ironridge Global BioPharma and its ... transactions, subject to certain conditions, to purchase common and ...
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
Cached Medicine Technology:ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 2ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6
(Date:5/21/2015)... (PRWEB) May 21, 2015 WellCare Health Plans, ... has been selected by the Florida Healthy Kids Corporation (FHKC) ... years of age, as part of the Florida Healthy Kids ... Oct. 1, 2015, and may be extended for two additional ... to serve children in the FHK program who live in ...
(Date:5/21/2015)... ChiliPad is a temperature-regulated mattress pad ... the bed so that users sleep comfortably all night ... bed can pick their ideal sleep temperature and maintain ... stay asleep longer. , Unlike other products, ChiliPad uses ... which produces a more concentrated temperature than circulated air. ...
(Date:5/21/2015)... Appleton, Wisconsin (PRWEB) May 21, 2015 The ... Barnas to a new full-time role as president. Barnas is ... leadership team. Her focus is to coach, lead and support ... to:, , Transforming the patient experience , ... Reducing healthcare costs across North America. , The ...
(Date:5/21/2015)... 21, 2015 Shimadzu Scientific Instruments ... autosampler, which features new time-saving tools to maximize ... techniques: liquid, headspace, and solid-phase microextraction (SPME), the ... tool allows users to seamlessly change injection techniques ... , The new autosampler allows for sample preparation ...
(Date:5/21/2015)... Northern Westchester Hospital announced ... at Northern Westchester Hospital, conducted an international broadcast of ... Intestinal Pylorus-Sparing Surgery or SIPS . This innovative ... and benefits patients by helping to stabilize blood glucose ... technique was broadcast live on May 19, 2015 to ...
Breaking Medicine News(10 mins):Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 3Health News:Kim Barnas joins ThedaCare Center for Healthcare Value 2Health News:Shimadzu’s New AOC-6000 Autosampler Makes Automated Sample Introduction Simple and Efficient 2Health News:Northern Westchester Hospital Surgeon Mitchell Roslin, MD Conducts International Broadcast of Bariatric Surgery Technique 2Health News:Northern Westchester Hospital Surgeon Mitchell Roslin, MD Conducts International Broadcast of Bariatric Surgery Technique 3
... in four Pakistani adults aged 15 years and above is ... link with hypertension and diabetes//. ,The study has ... similarities among the people's food habits and lifestyle in the ... that excess weight and obesity are a major health problem ...
... Researchers at the University of California, San Diego (UCSD) ... white blood cells that play key roles// in inflammation ... navigate to sites of infection and inflammation. These findings ... and inflammatory diseases in patients. ,The research, reported ...
... incidents, particularly those resulting in harm, warns a study ... the current system, which relies on voluntary reporting, may ... accurate information on the extent of harm resulting from ... common in hospitals, and many of them lead to ...
... resident doctors of All India Institute of Medical Sciences ... //in Lok Sabha on Thursday intensified with five more ... Anil Sharma, spokesman of the AIIMS Resident Doctors' Association, ... duty and services at AIIMS.' – Dr Sharma said. ...
... Australia, AMA Vice-President, Dr Choong-Siew Yong, today cautioned people ... take extra care during periods of smoke haze. ... anyone’s health, but that's particularly true for people with ... ,'Large airborne particles such as embers can irritate ...
... "Pascal" Norris died in July. The cause of his death ... an instrument maker and made African drums, and it is ... leather. ,Anthrax is caused by bacterium Bacillus anthracis ... goats but humans exposed to infected animals can also be ...
Cached Medicine News:Health News:Researchers Discover Internal Compass of Immune Cells 2Health News:Hospitals Miss Most Patient Safety Incidents 2Health News:Asthma Warning As Bushfires Burn 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: